<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd"><article xml:lang="en" dtd-version="1.3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article"><front><journal-meta><journal-id journal-id-type="issn">2685-5062</journal-id><journal-title-group><journal-title>Pharmacon: Jurnal Farmasi Indonesia</journal-title><abbrev-journal-title>pharmacon</abbrev-journal-title></journal-title-group><issn pub-type="epub">2685-5062</issn><issn pub-type="ppub">1411-4283</issn><publisher><publisher-name>Universitas Muhammadiyah Surakarta</publisher-name><publisher-loc>Main Building Siti Walidah 5th Floor, Pabelan, Kartasura, Sukoharjo, 57169. Jawa Tengah, INDONESIA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23917/pharmacon.v23i1.16383</article-id><title-group><article-title>Shallot Leaf Extract-Loaded Nanostructured Lipid Carrier as a Preliminary Platform for STMN1-Targeted Screening and Macrophage Phagocytic Activity Enhancement</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Falistina</surname><given-names>Amna</given-names></name><address><country>Indonesia</country></address><xref ref-type="aff" rid="AFF-1"></xref></contrib><contrib contrib-type="author"><name><surname>Alfisyahani</surname><given-names>Bilqis</given-names></name><address><country>Indonesia</country></address><xref ref-type="aff" rid="AFF-1"></xref></contrib><contrib contrib-type="author"><name><surname>Faturohman</surname><given-names>Yuda</given-names></name><address><country>Indonesia</country><email>yudafaturohman@students.unnes.ac.id</email></address><xref ref-type="aff" rid="AFF-2"></xref><xref ref-type="corresp" rid="cor-2"></xref></contrib><contrib contrib-type="author"><name><surname>Riyandino</surname><given-names>Adyatma</given-names></name><address><country>Indonesia</country></address><xref ref-type="aff" rid="AFF-2"></xref></contrib><contrib contrib-type="author"><name><surname>Kumara</surname><given-names>Anantazea Deniss</given-names></name><address><country>Indonesia</country></address><xref ref-type="aff" rid="AFF-3"></xref></contrib><contrib contrib-type="author"><name><surname>Widianingrum</surname><given-names>Talitha</given-names></name><address><country>Indonesia</country></address><xref ref-type="aff" rid="AFF-1"></xref></contrib></contrib-group><aff id="AFF-1"><institution content-type="dept">Biology, Faculty of Mathematics and Natural Sciences</institution><institution-wrap><institution>Universitas Negeri Semarang</institution><institution-id institution-id-type="ror">https://ror.org/02fsk7e17</institution-id></institution-wrap><country country="ID">Indonesia</country></aff><aff id="AFF-2"><institution content-type="dept">Chemistry Education, Faculty of Mathematics and Natural Sciences</institution><institution-wrap><institution>Universitas Negeri Semarang</institution><institution-id institution-id-type="ror">https://ror.org/02fsk7e17</institution-id></institution-wrap><country country="ID">Indonesia</country></aff><aff id="AFF-3"><institution content-type="dept">Pharmacy Studi Program, Faculty of Medicine</institution><institution-wrap><institution>Universitas Negeri Semarang</institution><institution-id institution-id-type="ror">https://ror.org/02fsk7e17</institution-id></institution-wrap><country country="ID">Indonesia</country></aff><author-notes><corresp id="cor-2">Corresponding author: Yuda Faturohman, Chemistry Education, Faculty of Mathematics and Natural Sciences, Universitas Negeri Semarang, Indonesia.  Email: <email>yudafaturohman@students.unnes.ac.id</email></corresp></author-notes><pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-6-30"><day>30</day><month>6</month><year>2026</year></pub-date><pub-date date-type="collection" iso-8601-date="2026-6-30" publication-format="electronic"><day>30</day><month>6</month><year>2026</year></pub-date><volume>23</volume><issue>1</issue><fpage>112</fpage><lpage>121</lpage><history><date date-type="received" iso-8601-date="2026-2-23"><day>23</day><month>2</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-6-25"><day>25</day><month>6</month><year>2026</year></date></history><permissions><copyright-statement>Copyright (c) 2026 Pharmacon: Jurnal Farmasi Indonesia</copyright-statement><copyright-year>2026</copyright-year><copyright-holder>Pharmacon: Jurnal Farmasi Indonesia</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Copyright (c) 2026 Pharmacon: Jurnal Farmasi Indonesia</license-p></license></permissions><self-uri xlink:href="https://journals2.ums.ac.id/pharmacon/article/view/16383" xlink:title="Shallot Leaf Extract-Loaded Nanostructured Lipid Carrier as a Preliminary Platform for STMN1-Targeted Screening and Macrophage Phagocytic Activity Enhancement">Shallot Leaf Extract-Loaded Nanostructured Lipid Carrier as a Preliminary Platform for STMN1-Targeted Screening and Macrophage Phagocytic Activity Enhancement</self-uri><abstract><p>Cancer metastasis remains a major therapeutic challenge involving molecular dysregulation and tumor–microenvironment interactions. Stathmin 1 (STMN1), a microtubule-destabilizing regulator related to cell motility and tumor aggressiveness, is relevant for preliminary anti-metastasis-oriented screening. Nanostructured lipid carriers (NLC) may improve the dispersion and delivery performance of natural-product extracts. This study formulated shallot leaf (<italic>Allium cepa</italic> L.) extract into an NLC dispersion using emulsification–ultrasonication under homogenized and non-homogenized conditions, followed by PSA/DLS and SEM characterization. Phytochemical candidates curated from databases and literature were docked to STMN1 to identify ligands with favorable predicted binding profiles. Macrophage phagocytic function was evaluated using a latex-bead assay at 0, 5, and 10 µL. PSA/DLS and SEM indicated particulate structures, but particle-size variation and aggregation suggested the need for further formulation optimization and stability evaluation. Docking ranked sinapic acid (−7.5 kcal/mol) and ferulic acid (−7.4 kcal/mol) as the best phenolic candidates among the tested ligands, although the GDP control showed stronger predicted affinity. Phagocytic capacity increased from 33.5% (0 µL) to 37% (5 µL) and 91% (10 µL), while the phagocytic index increased from 0.63 to 0.77 and 4.50, respectively. The 10 µL dose was the most responsive condition for enhancing macrophage phagocytic activity. These findings should be interpreted as preliminary evidence of STMN1-oriented in silico prioritization and macrophage functional enhancement, not direct proof of anti-metastatic activity or M2 macrophage inhibition.</p></abstract><kwd-group><kwd>Lipid carriers</kwd><kwd>Macrophage phagocytosis</kwd><kwd>Molecular docking</kwd><kwd>Nanostructured</kwd><kwd>Shallot leaf extract</kwd><kwd>STMN1</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>File created by JATS Editor</meta-name><meta-value><ext-link ext-link-type="uri" xlink:href="https://jatseditor.com" xlink:title="JATS Editor">JATS Editor</ext-link></meta-value></custom-meta><custom-meta><meta-name>issue-created-year</meta-name><meta-value>2026</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Cancer is a disease characterized by uncontrolled proliferation of abnormal cells that can invade surrounding tissues and spread to distant organs through metastasis. Global estimates from GLOBOCAN 2022 report nearly 20 million new cancer cases and approximately 9.7 million deaths, indicating that the need for therapeutic innovation remains high worldwide <xref ref-type="bibr" rid="BIBR-2">(Bray et al., 2024)</xref>. Metastasis represents a critical challenge because it is strongly associated with treatment failure at advanced stages and with poorer clinical outcomes <xref ref-type="bibr" rid="BIBR-32">(Zeng et al., 2024)</xref>. Microtubule dynamics play an essential role in cell migration, making stathmin 1 (STMN1), a microtubule-destabilizing regulator, frequently associated with tumor aggressiveness and metastatic behavior. Recent evidence indicates that STMN1 can contribute to metastasis through microtubule-related mechanisms and has therefore been considered a potential molecular target for anti-metastatic intervention <xref ref-type="bibr" rid="BIBR-22">(Liu et al., 2023)</xref>. The tumor microenvironment is also shaped by innate immune cells, particularly macrophages, which can “partner” with tumor cells to promote directed migration and support metastatic progression<xref ref-type="bibr" rid="BIBR-10">(Friedman-DeLuca et al., 2024)</xref>.</p><p>Recent advances in topical drug delivery have positioned Nanostructured Lipid Carriers (NLC) as lipid-based nanocarriers capable of improving loading capacity, stability, and sustained release <xref ref-type="bibr" rid="BIBR-20">(Kumari et al., 2026)</xref>. Incorporation of NLC into hydrogel matrices has been reported to enhance application comfort, prolong local residence time, and improve drug retention within skin layers <xref rid="BIBR-4" ref-type="bibr">(Calderon-Jacinto et al., 2022)</xref>. Natural-product research on the genus <italic>Allium</italic> has highlighted the presence of flavonoids and organosulfur compounds with potential anticancer activity through diverse biological mechanisms <xref ref-type="bibr" rid="BIBR-13">(Imran et al., 2020)</xref><xref ref-type="bibr" rid="BIBR-14">(Iwar et al., 2024)</xref>. The resulting gap creates an opportunity to integrate an <italic>Allium</italic>-based NLC–gel platform with mechanistic evaluation connecting STMN1 targeting and macrophage responses as key components of the metastatic microenvironment <xref ref-type="bibr" rid="BIBR-10">(Friedman-DeLuca et al., 2024)</xref>.</p><p>This study offers novelty through the development of a shallot leaf extract-loaded NLC dispersion and its evaluation using a staged evidentiary workflow spanning formulation, in silico target exploration, and macrophage functional assessment. The study aims to formulate an NLC system containing shallot leaf extract and incorporate it into a gel base to enhance stability and topical performance. Additional objectives include characterization of product quality, including particle size, PDI, zeta potential, morphology, and gel-related parameters required to establish formulation feasibility <xref ref-type="bibr" rid="BIBR-4">(Calderon-Jacinto et al., 2022)</xref>. Mechanistic objectives focus on identifying selected compounds from the extract and evaluating their predicted binding affinity toward STMN1, a target associated with migration and metastasis in specific cancer contexts <xref ref-type="bibr" rid="BIBR-22">(Liu et al., 2023)</xref>. Biological objectives focus on testing macrophage responses using a functional phagocytosis assay to capture early trends in innate immune modulation, without directly claiming macrophage polarization or M2 inhibition in the absence of marker-based evidence <xref ref-type="bibr" rid="BIBR-10">(Friedman-DeLuca et al., 2024)</xref>.</p></sec><sec><title>METHODS</title><sec><title>Formulation of Shallot-Leaf NLC Nanoparticles</title><sec><title>Plant Material Preparation and Maceration Extraction</title><p>Shallot leaves (<italic>Allium cepa</italic> L.) were washed, drained, dried, and milled into fine simplisia powder. The powdered simplisia (300 g) was macerated with 96% technical ethanol (1.8 L) for 3 × 24 h at room temperature with occasional stirring. The filtrate was collected and concentrated by solvent evaporation to obtain a viscous crude extract <xref rid="BIBR-19" ref-type="bibr">(Krakowska-Sieprawska et al., 2022)</xref>.</p></sec><sec><title>Preparation of nanostructured lipid carriers (NLC) by emulsification–ultrasonication</title><p>Nanostructured lipid carriers (NLC) were prepared using an emulsification–ultrasonication approach adapted from published NLC preparation methods <xref ref-type="bibr" rid="BIBR-8">(Elkhateeb et al., 2023)</xref>. Oil phase consisted of shallot leaf extract (0.5 mL), glyceryl monostearate (7 mL), capric acid (3 mL), and lecithin (5 mL). Aqueous phase consisted of Tween 80 (2 mL) and ultrapure water (67.5 mL). Oil and aqueous phases were heated separately to 70 °C, then the aqueous phase was added dropwise to the oil phase at 70 °C under continuous agitation (8000 rpm). Emulsions were immediately subjected to high-intensity sonication for 10 min followed by cooling to room temperature.</p></sec></sec><sec><title>Experimental characterization</title><sec><title>Particle size distribution and polydispersity</title><p>Particle size and polydispersity index (PDI) were measured using a Particle Size Analyzer (PSA). The NLC dispersion was diluted with distilled water to obtain a 100 ppm colloid, transferred into a cuvette, and analyzed to determine particle size and polydispersity index.</p></sec><sec><title>Morphological Characterization of NLC by SEM</title><p>Scanning electron microscopy (SEM) was used to observe surface morphology. Sample preparation and imaging followed the standard SEM workflow available in the hosting facility.</p></sec></sec><sec><title>In silico analysis: STMN1 (stathmin) docking</title><sec><title>Ligand collection and preparation</title><p>Bioactive compounds were compiled from Dr. Duke’s Phytochemical and Ethnobotanical Database using the keyword “<italic>Allium cepa</italic>,” <xref ref-type="bibr" rid="BIBR-7">(Duke, 2016)</xref>. Ligand structures were retrieved from PubChem in SDF format <xref ref-type="bibr" rid="BIBR-18">(Kim et al., 2023)</xref>.</p></sec><sec><title>Protein target preparation (STMN1)</title><p>Stathmin (STMN1) was defined as the docking target. A 3D structure model for STMN1 was obtained from the AlphaFold Protein Structure Database (AlphaFold DB) <xref ref-type="bibr" rid="BIBR-29">(Unknown Author, n.d.)</xref>. Protein preprocessing included removal of non-essential molecules (e.g., waters) and basic structure cleaning using PyMOL</p></sec><sec><title>Molecular docking and interaction analysis</title><p>Docking simulations were carried out using AutoDock Vina through the PyRx 0.8 interface <xref ref-type="bibr" rid="BIBR-27">(Trott &amp; Olson, 2010)</xref>. Docking outputs were saved in PDBQT format for downstream visualization and analysis. Binding poses were visualized in PyMOL, and 2D interaction diagrams were generated using LigPlot+ to summarize hydrogen bonding and hydrophobic contacts.</p></sec></sec><sec><title>In vitro assay: macrophage phagocytosis using latex beads</title><sec><title>Treatment design</title><p>Macrophage cultures were prepared following the laboratory’s established workflow. NLC formulation was applied at volume-based doses of 0 µL, 5 µL, and 10 µL, with two experimental repeats per condition (as conducted), and incubated for 4 h.</p></sec><sec><title>Latex bead challenge, fixation, and staining</title><p>Latex bead phagocytosis was used as the functional readout of macrophage activity. After treatment incubation, residual formulation was removed and 200 µL latex bead suspension was added to each culture, followed by 60 min incubation. Uninternalized beads were removed by washing, cells were rinsed with PBS, fixed using methanol, air-dried at room temperature, and stained with 10% Giemsa.</p></sec><sec><title>Microscopy and quantification</title><p>Light microscopy at 400× magnification was used to quantify phagocytosis by counting (i) the number of macrophages actively phagocytosing per 100 macrophages (phagocytic capacity) and (ii) the number of internalized beads per 100 macrophages (phagocytic index). Data were analyzed using one-way ANOVA at a significance level of α = 0.05. When the homogeneity assumption was met, Tukey’s HSD was applied for pairwise comparisons. When variances were unequal (heteroscedasticity), the Games–Howell post hoc test was used for multiple comparisons <xref rid="BIBR-24" ref-type="bibr">(Pavlova et al., 2023)</xref>.</p></sec></sec></sec><sec><title>RESULT</title><sec><title>Preparation of NLC dispersions</title><p>Preparation of the NLC dispersions produced two formulations with distinct visual appearances under the non-homogenized and homogenized conditions <xref ref-type="bibr" rid="BIBR-8">(Elkhateeb et al., 2023)</xref>. The non-homogenized dispersion exhibited lower visual uniformity than the homogenized dispersion. The homogenized dispersion appeared more visually uniform than the non-homogenized sample <xref ref-type="bibr" rid="BIBR-20">(Kumari et al., 2026)</xref>.</p><fig id="figure-1" ignoredToc=""><label>Figure 1</label><caption><p>Results of NLC gel synthesis: (a) without homogenization; (b) homogenized.</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80486"><alt-text>Image</alt-text></graphic></fig><sec><title>Particle size and polydispersity index</title><p>Particle size and dispersity were measured using a Particle Size Analyzer (PSA) operated under the dynamic light scattering (DLS) principle <xref ref-type="bibr" rid="BIBR-12">(Hackley &amp; Clogston, 2020)</xref>. The particle-size profiles differed between the homogenized and non-homogenized preparations.</p><p>The homogenized sample showed a small-size peak at 2.3 nm (<xref ref-type="fig" rid="figure-2">Figure 2</xref>), whereas the non-homogenized sample showed a peak at 33.9 nm (<xref ref-type="fig" rid="figure-3">Figure 3</xref>). Nevertheless, the 2.3 nm peak was interpreted cautiously because this size is below the typical dimension expected for intact lipid-core NLC particles and may correspond to micellar or surfactant-associated colloidal species. The dispersion also showed a Z-average of 3729.2 nm and a polydispersity index (PDI) of 0.340.</p><fig id="figure-2" ignoredToc=""><label>Figure 2</label><caption><p>PSA results of homogenized NLCs.</p></caption><graphic mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80487" mime-subtype="png"><alt-text>Image</alt-text></graphic></fig><fig id="figure-3" ignoredToc=""><label>Figure 3</label><caption><p>PSA results of non-homogenized NLCs.</p></caption><graphic mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80488" mime-subtype="png"><alt-text>Image</alt-text></graphic></fig></sec></sec><sec><title>Morphological characterization of NLC by SEM</title><fig id="figure-4" ignoredToc=""><label>Figure 4</label><caption><p>SEM analysis results of NLCs.</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80489"><alt-text>Image</alt-text></graphic></fig><p>Morphological characterization of the prepared NLC dispersions was performed using scanning electron microscopy (SEM). The SEM micrographs revealed particulate structures with irregular morphology and a tendency to form aggregates rather than discrete, uniformly separated spherical nanoparticles (<xref ref-type="fig" rid="figure-4">Figure 4</xref>).</p><p>The presence of particle clusters and uneven surface features suggests that agglomeration may have occurred during sample preparation, drying, or imaging, which is commonly observed in electron microscopy analysis of colloidal lipid-based systems <xref rid="BIBR-3" ref-type="bibr">(Bresch et al., 2022)</xref>. These observations are consistent with the PSA results, which indicated the presence of larger particle populations or aggregates in the dispersion. Therefore, the SEM results support the formation of particulate structures in the prepared dispersion, but they do not yet provide sufficient evidence to confirm a fully uniform and physically stable NLC system. Further optimization of the formulation process and additional stability evaluations, including zeta potential measurement and storage stability testing, are required to confirm colloidal stability and reduce aggregation <xref ref-type="bibr" rid="BIBR-5">(Chauhan et al., 2020)</xref>.</p></sec><sec><title>Molecular docking results against STMN1</title><fig id="figure-5" ignoredToc=""><label>Figure 5</label><caption><p>Chemical structures of candidate ligands and the STMN1 target protein prepared for docking analysis, a) Ferulic Acid; b) Protocatechuic Acid; c) Sinapic Acid; d) Acetic Acid; e) Butanoic Acid; f) 3-[2-(N-methylaminomethyl)phenylthio]phenol; g) Protein stathmin.</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80490"><alt-text>Image</alt-text></graphic></fig><fig id="figure-6" ignoredToc=""><label>Figure 6</label><caption><p>Molecular docking visualization of phosphorylated STMN1 (stathmin): 3D structure of the stathmin–phosphate complex</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80491"><alt-text>Image</alt-text></graphic></fig><p>Candidate ligands for molecular docking against STMN1 (stathmin) were curated from Dr. Duke’s Phytochemical and Ethnobotanical Database and matched with 3D structures from PubChem prior to docking simulations to evaluate binding affinity and identify interacting residues (<xref ref-type="bibr" rid="BIBR-7">(Duke, 2016)</xref>; <xref ref-type="bibr" rid="BIBR-27">(Trott &amp; Olson, 2010)</xref>). A phosphate group was incorporated into the STMN1 model because STMN1 is regulated by phosphorylation, and phosphorylation at key serine residues  is known to modulate stathmin’s microtubule-related activity in cancer-relevant contexts <xref ref-type="bibr" rid="BIBR-22">(Liu et al., 2023)</xref>. The ligand collection and the STMN1 model are illustrated in <xref ref-type="fig" rid="figure-5">Figure 5</xref>, whereas the docked poses within the binding pocket and their interaction representations together with the phosphorylated STMN1 visualization are shown in <xref rid="figure-6" ref-type="fig">Figure 6</xref>.</p><p>Docking analysis showed that the control ligand GDP exhibited the strongest binding affinity (−10.6 kcal/mol), whereas among the tested compounds, sinapic acid (−7.5 kcal/mol) and ferulic acid (−7.4 kcal/mol) demonstrated higher affinities than protocatechuic acid (−6.6kcal/mol) (<xref ref-type="table" rid="table-1">Table 1</xref>). Recurrent interactions involving residues such as GLN11, CYS12, SER138, GLY142, and THR143 suggested a relatively conserved binding region within STMN1 <xref ref-type="bibr" rid="BIBR-32">(Zeng et al., 2024)</xref>. Overall, sinapic acid and ferulic acid emerged as the most promising candidate ligands, although their predicted binding affinities remained lower than that of the control ligand GDP (<xref ref-type="bibr" rid="BIBR-23">(Papagiouvannis et al., 2024)</xref>; <xref ref-type="bibr" rid="BIBR-26">(Theodosis-Nobelos et al., 2023)</xref>)</p><table-wrap ignoredToc="" id="table-1"><label>Table 1</label><caption><p>STMN1–ligand interaction map derived from docking and LigPlot+ analysis: key residues, functional groups, and contact distances</p></caption><table frame="box" rules="all"><thead><tr><th align="left" colspan="1" valign="top">Substances</th><th valign="top" align="left" colspan="1">Binding affinity (kcal/mol)</th><th align="left" colspan="1" valign="top">Binding distance (A0)</th><th valign="top" align="left" colspan="1">Amino acid and the bound funct. groups</th><th align="left" colspan="1" valign="top">2D binding depiction</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="1">GDP Ligand control</td><td valign="top" align="left" colspan="1">-10.6</td><td colspan="1" valign="top" align="left">2,78 2,61 2,89 2,75 3,28 3,11 3,26 3,06 2,96 2,86 2,84 2,76 2,84 2,68</td><td valign="top" align="left" colspan="1">TYR222: H-O ASN226: H-O ASN226: H-O ASN204: H-O ASN204: H-O VALL75: alkyl SER138: H-O SER138: H-O SER138: H-O CYS12: H-O GLY144: H-O GLN11: H-O GLY142: H-O THR143:H-O</td><td valign="top" align="left" colspan="1"><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80492"><alt-text>Image</alt-text></graphic></td></tr><tr><td valign="top" align="left" colspan="1">Ferulic Acid</td><td valign="top" align="left" colspan="1">-7.4</td><td align="left" colspan="1" valign="top">2,97 3,03 3,08 3,22 3,11 3,09 2,88 3,01</td><td colspan="1" valign="top" align="left">GLN11: H-O  CYS12: H-O GLY13: C-H SER138: H-O ALA9: alkyl ASN204: H-O GLY142: C-H THR143: H-O</td><td valign="top" align="left" colspan="1"><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80493"><alt-text>Image</alt-text></graphic></td></tr><tr><td valign="top" align="left" colspan="1">Sinapic Acid</td><td valign="top" align="left" colspan="1">-7.5</td><td align="left" colspan="1" valign="top">2,75 3,11 3,20 3,18 3,17 2,71 3,01</td><td valign="top" align="left" colspan="1">ASN99: H-O THR143: H-O GLY142: C-H GLY142: C-H SER138: H-O SER138: H-O SER145: C-H</td><td valign="top" align="left" colspan="1"><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80494"><alt-text>Image</alt-text></graphic></td></tr><tr><td align="left" colspan="1" valign="top">Protocatechuic Acid</td><td valign="top" align="left" colspan="1">-6.6</td><td valign="top" align="left" colspan="1">2,57 3,16 3,03 2,78 3,05 3,20 3,19 2,98 2,80 2,92</td><td valign="top" align="left" colspan="1">GLY142: C-H GLY142: C-H ASN99: H-O ASN99: H-O ASN99: H-O SER138: H-O  THR143: H-O THR143:H-O THR143: H-O GLY144: C–H</td><td align="left" colspan="1" valign="top"><break></break><graphic xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80481" mime-subtype="png" mimetype="image"><alt-text>Image</alt-text></graphic></td></tr></tbody></table></table-wrap></sec><sec><title>Macrophage isolation and culture observations</title><p>Peritoneal macrophages isolated from BALB/c mice produced a cell suspension suitable for microscopy-based analysis. The coverslip preparation provided a denser and more clearly distinguishable cell distribution than the non-coverslip condition (<xref ref-type="fig" rid="figure-7">Figure 7</xref>). Hemocytometer counting showed a cell density of 1.89 × 10⁶ cells/mL, confirming that the isolated cells were adequate for subsequent morphological observation and the latex-bead phagocytosis assay<xref ref-type="bibr" rid="BIBR-11">(Green &amp; Sambrook, 2019)</xref>.</p><fig ignoredToc="" id="figure-7"><label>Figure 7</label><caption><p>Results of isolation of peritoneal cavity macrophage cells from BALB/c mice (Mus musculus) without coverslip (a) and with coverslip (b).</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80482"><alt-text>Image</alt-text></graphic></fig></sec><sec><title>Macrophage isolation and culture observation</title><fig id="figure-8" ignoredToc=""><label>Figure 8</label><caption><p>Morphology of macrophage cells treated with 0 µL (a), 5 µL (b), and 10 µL (c). Note: (n) nucleus, (s) cytoplasm, (l) latex beads (400× magnification).</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80483"><alt-text>Image</alt-text></graphic></fig><p>Microscopic examination of 10% Giemsa-stained macrophages at 400× magnification clearly distinguished the nuclei and cytoplasm, enabling reliable cell identification <xref ref-type="bibr" rid="BIBR-31">(Velez-Hoyos &amp; Jimenez-tobon, 2022)</xref>. Representative micrographs (<xref ref-type="fig" rid="figure-8">Figure 8</xref>) showed a dose-dependent increase in latex bead uptake, with the highest bead density observed in the 10 µL group. The observed cell size (approximately 15–26 µm) was consistent with the typical morphology of macrophages <xref ref-type="bibr" rid="BIBR-9">(Fakoya et al., 2025)</xref>.</p><fig id="figure-9" ignoredToc=""><label>Figure 9</label><caption><p>Diagram of phagocytic capacity.</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80484"><alt-text>Image</alt-text></graphic></fig><table-wrap ignoredToc="" id="table-2"><label>Table 2</label><caption><p>Results of the Games–Howell post hoc test on phagocytic capacity.</p></caption><table frame="box" rules="all"><thead><tr><th align="left" colspan="1" valign="top">Concentration (µL/mL)</th><th valign="top" align="left" colspan="1">Compared with (µL/mL)</th><th valign="top" align="left" colspan="1">Mean Difference</th><th align="left" colspan="1" valign="top">Sig.</th><th align="left" colspan="1" valign="top">p (α = 0.05)</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="1" rowspan="2">0</td><td align="left" colspan="1" valign="top">5</td><td align="left" colspan="1" valign="top">−3.33</td><td valign="top" align="left" colspan="1">0.143</td><td align="left" colspan="1" valign="top">&lt; 0.05</td></tr><tr><td align="left" colspan="1" valign="top">10</td><td valign="top" align="left" colspan="1">−56.00*</td><td colspan="1" valign="top" align="left">&lt;0.001</td><td valign="top" align="left" colspan="1">&lt; 0.05</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">5</td><td valign="top" align="left" colspan="1">0</td><td align="left" colspan="1" valign="top">3.33</td><td valign="top" align="left" colspan="1">0.143</td><td valign="top" align="left" colspan="1">&lt; 0.05</td></tr><tr><td colspan="1" valign="top" align="left">10</td><td colspan="1" valign="top" align="left">−52.66*</td><td valign="top" align="left" colspan="1">&lt;0.001</td><td valign="top" align="left" colspan="1">&lt; 0.05</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">10</td><td valign="top" align="left" colspan="1">0</td><td valign="top" align="left" colspan="1">56.00*</td><td align="left" colspan="1" valign="top">&lt;0.001</td><td valign="top" align="left" colspan="1">&lt; 0.05</td></tr><tr><td valign="top" align="left" colspan="1">5</td><td valign="top" align="left" colspan="1">52.66*</td><td align="left" colspan="1" valign="top">&lt;0.001</td><td valign="top" align="left" colspan="1">&lt; 0.05</td></tr></tbody></table></table-wrap></sec><sec><title>Phagocytic capacity of macrophages</title><p>Phagocytic capacity differed among treatment groups. The control (0 µL), 5 µL, and 10 µL groups exhibited phagocytic capacities of 33.5%, 37%, and 91%, respectively (<xref ref-type="fig" rid="figure-9">Figure 9</xref>). Games–Howell analysis showed no significant difference between the 0 and 5 µL groups (p = 0.143), whereas significant differences were observed between the 0 and 10 µL groups and between the 5 and 10 µL groups (both p &lt; 0.001) (<xref ref-type="table" rid="table-2">Table 2</xref>).</p></sec><sec><title>Macrophage phagocytosis assay observations</title><fig id="figure-10" ignoredToc=""><label>Figure 10</label><caption><p>Diagram of the macrophage phagocytic index.</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="https://journals2.ums.ac.id/pharmacon/article/download/16383/6181/80485"><alt-text>Image</alt-text></graphic></fig><table-wrap id="table-3" ignoredToc=""><label>Table 3</label><caption><p>Results of the Games–Howell post hoc test on the phagocytic index.</p></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="left" colspan="2">Concentration (µl/mL)</th><th valign="top" align="left" colspan="1">Mean Difference</th><th valign="top" align="left" colspan="1">Sig.</th><th valign="top" align="left" colspan="1">P</th><th colspan="1" valign="top" align="left">Conclusion</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="2" valign="top"><p>0</p><break></break></td><td valign="top" align="left" colspan="1">5</td><td valign="top" align="left" colspan="1">-0,191*</td><td valign="top" align="left" colspan="1">0,044</td><td colspan="1" rowspan="6" valign="top" align="left">&lt; 0,05</td><td align="left" colspan="1" rowspan="6" valign="top">Significant</td></tr><tr><td align="left" colspan="1" valign="top">10</td><td align="left" colspan="1" valign="top">-3,080*</td><td valign="top" align="left" colspan="1">0,016</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1"><p>5</p><break></break></td><td align="left" colspan="1" valign="top">0</td><td valign="top" align="left" colspan="1">0,191*</td><td valign="top" align="left" colspan="1">0,044</td></tr><tr><td align="left" colspan="1" valign="top">10</td><td align="left" colspan="1" valign="top">-2,888*</td><td align="left" colspan="1" valign="top">0,020</td></tr><tr><td align="left" colspan="1" rowspan="2" valign="top"><p>10</p><break></break></td><td align="left" colspan="1" valign="top">0</td><td valign="top" align="left" colspan="1">3,080*</td><td valign="top" align="left" colspan="1">0,016</td></tr><tr><td valign="top" align="left" colspan="1">5</td><td valign="top" align="left" colspan="1">2,888*</td><td valign="top" align="left" colspan="1">0,020</td></tr></tbody></table></table-wrap><p>The macrophage phagocytic index exhibited a sharper change than phagocytic capacity, capturing not only “how many cells are active” but also “how intensively” the participating cells internalize particles. The macrophage phagocytic index increased from 0.63 in the control group (0 µL) to 0.77 at 5 µL and rose markedly to 4.50 at 10 µL (<xref ref-type="fig" rid="figure-10">Figure 10</xref>), indicating a dose-dependent enhancement in phagocytic activity. Games–Howell post hoc analysis confirmed significant differences among all treatment groups (p &lt; 0.05) (<xref ref-type="table" rid="table-3">Table 3</xref>). Although the 5 µL treatment produced only a modest increase, the 10 µL dose resulted in a substantially greater enhancement of phagocytic activity.</p></sec></sec><sec><title>DISCUSSION</title><sec><title>In silico prediction of STMN1 interaction by shallot-derived candidate ligands</title><p>Candidate ligands curated from phytochemical databases and literature sources were docked to STMN1, and the resulting binding affinities and interaction profiles were evaluated as a first-pass in silico screen of predicted STMN1 interaction <xref ref-type="bibr" rid="BIBR-27">(Trott &amp; Olson, 2010)</xref>. Docking outcomes showed that the GDP control ligand produced the strongest predicted affinity (−10.6 kcal/mol) and formed multiple short-range contacts within the binding pocket, serving as a benchmark for comparison (<xref ref-type="table" rid="table-1">Table 1</xref>). Among the tested phenolic acids, sinapic acid (−7.5 kcal/mol) and ferulic acid (−7.4 kcal/mol) showed the most favorable predicted binding affinities, whereas protocatechuic acid (−6.6 kcal/mol) showed weaker predicted binding (<xref ref-type="table" rid="table-1">Table 1</xref>). Although the candidate ligands did not surpass the control, the affinity ordering suggests a possible trend in which substituted phenolic acids with more extensive functionalization may show more favorable predicted interactions within the STMN1 pocket under the present docking conditions <xref ref-type="bibr" rid="BIBR-32">(Zeng et al., 2024)</xref>.</p><p>Interaction mapping further supports this ranking by highlighting recurring residues and plausible contact chemistry. Several residues appeared repeatedly across ligand–STMN1 complexes (e.g., SER138, GLY142, THR143, and GLN11/CYS12), suggesting that multiple ligands may occupy a relatively consistent predicted binding region of STMN1 (<xref ref-type="table" rid="table-1">Table 1</xref>). Collectively, the docking results indicate that sinapic acid and ferulic acid showed the most favorable predicted interactions among the tested candidates and therefore represent the strongest in silico candidates for further STMN1-oriented evaluation in this study. At the same time, docking remains a predictive approach; recent evaluations emphasize that scoring functions and sampling limitations require cautious interpretation and that experimental validation is needed before concluding biochemical inhibition <xref ref-type="bibr" rid="BIBR-1">(Agu et al., 2023)</xref>.</p></sec><sec><title>In vitro macrophage functional response to NLC treatment</title><p>In vitro testing was conducted to evaluate whether the synthesized NLC dispersion could modulate macrophage phagocytosis as an early functional readout related to innate immune response in the tumor microenvironment. Peritoneal macrophages isolated from BALB/c mice produced a cell suspension suitable for microscopy-based assays, and the coverslip preparation enabled clearer observation than the non-coverslip condition  (<xref ref-type="fig" rid="figure-7">Figure 7</xref>) (<xref ref-type="bibr" rid="BIBR-6">(Jesus et al., 2022)</xref>; <xref ref-type="bibr" rid="BIBR-17">(Khatua et al., 2022)</xref>). Giemsa-stained micrographs showed distinguishable nuclei and cytoplasm, as well as latex beads associated with macrophages across treatment groups, supporting the feasibility of quantitative phagocytosis analysis (<xref ref-type="fig" rid="figure-8">Figure 8</xref>) <xref ref-type="bibr" rid="BIBR-6">(Jesus et al., 2022)</xref>).</p><p>The biological response should be considered in relation to the physicochemical characteristics of the synthesized NLC system. Visual observation showed differences between homogenized and non-homogenized preparations (<xref rid="figure-1" ref-type="fig">Figure 1</xref>), while PSA/DLS analysis indicated particle-size variation and moderate dispersity (<xref ref-type="fig" rid="figure-2">Figure 2</xref> and <xref ref-type="fig" rid="figure-3">Figure 3</xref>). SEM observation also revealed irregular particulate structures with aggregation tendency (<xref rid="figure-4" ref-type="fig">Figure 4</xref>). These findings suggest that the NLC system delivered to macrophages consisted of lipid-based particulate entities whose dispersion state may influence cell-particle interaction, membrane contact, and bead uptake response.</p><p>Quantitative analysis showed that the 10 µL treatment produced the strongest enhancement of macrophage phagocytic activity. Phagocytic capacity increased from 33.5% (0 µL) to 37% (5 µL) and 91% (10 µL), with significant differences between 10 µL and both lower groups (p &lt; 0.001), while the 0 µL and 5 µL groups did not differ significantly (<xref ref-type="table" rid="table-2">Table </xref>2). The phagocytic index also increased from 0.63 to 0.77 and 4.50, respectively, with all pairwise comparisons showing significant differences (p &lt; 0.05) (<xref ref-type="table" rid="table-3">Table 3</xref>). These results indicate that the 10 µL NLC treatment increased both the proportion of active macrophages and the intensity of bead internalization, providing evidence of enhanced macrophage functional activity (<xref ref-type="bibr" rid="BIBR-25">(Riezk et al., 2025)</xref>; <xref ref-type="bibr" rid="BIBR-28">(Ueno et al., 2021)</xref>).</p><p>However, these findings should not be interpreted as direct evidence of anti-metastatic activity or M2 macrophage inhibition, since macrophage polarization markers such as CD206, CD163, Arg-1, IL-10, iNOS, and CD86 were not assessed. Further studies using marker-based assays and macrophage-cancer cell co-culture or migration assays are required to confirm phenotype-specific and anti-metastatic relevance (<xref ref-type="bibr" rid="BIBR-21">(Lim et al., 2024)</xref>; <xref ref-type="bibr" rid="BIBR-15">(Jeitler et al., 2024)</xref>).</p></sec></sec><sec><title>CONCLUSIONS</title><p>Shallot leaf extract was formulated into an NLC dispersion using an emulsification–ultrasonication approach. PSA/DLS and SEM findings indicated the presence of particulate structures. In silico docking against STMN1 identified sinapic acid and ferulic acid as the best-ranked phenolic candidates among the tested ligands. Macrophage testing showed that the 10 µL dose produced the strongest enhancement of phagocytic capacity and phagocytic index under the present latex-bead assay conditions. Further studies involving macrophage polarization markers are required to validate the formulation stability and biological relevance of the synthesized NLC dispersion.</p></sec><sec><title>ACKNOWLEDGMENT</title><p>The authors have no acknowledgments.</p></sec><sec><title>AUTHORS’ CONTRIBUTIONS</title><p>Amna Falistina (A.F.): Investigation; Data curation; Writing—original draft.</p><p>Bilqis Alfisyahani (B.A.): Investigation; Formal analysis; Visualization; Writing—original draft.</p><p>Yuda Faturohman (Y.F.): Conceptualization; Methodology; Formal analysis; Software; Supervision; Project administration; Writing—review &amp; editing.</p><p>Adyatma Riyandino (A.R.): Methodology; Writing—review &amp; editing.</p><p>Anantazea Deniss Kumara (A.D.K.): Supervision; Writing—review &amp; editing.</p><p>Talitha Widiatningrum (T.W.): Conceptualization; Investigation (laboratory work); Supervision; Writing—review &amp; editing.</p></sec><sec><title>CONFLICT OF INTERESTS</title><p>Authors declare no conflict of interest.</p></sec><sec><title>ETHICAL CONSIDEATION</title><p>Ethical approval was not required for this study.</p></sec></body><back><ref-list><title>References</title><ref id="BIBR-1"><element-citation publication-type="journal"><article-title>Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management</article-title><source>Sci. Rep</source><volume>13</volume><issue>1</issue><person-group person-group-type="author"><name><surname>Agu</surname><given-names>P.C.</given-names></name><name><surname>Afiukwa</surname><given-names>C.A.</given-names></name><name><surname>Orji</surname><given-names>O.U.</given-names></name><name><surname>Ezeh</surname><given-names>E.M.</given-names></name><name><surname>Ofoke</surname><given-names>I.H.</given-names></name><name><surname>Ogbu</surname><given-names>C.O.</given-names></name><name><surname>Ugwuja</surname><given-names>E.I.</given-names></name><name><surname>Aja</surname><given-names>P.M.</given-names></name></person-group><year>2023</year><page-range>13398</page-range></element-citation></ref><ref id="BIBR-2"><element-citation publication-type="webpage"><article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><volume>3</volume><issue>74</issue><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F.</given-names></name><name><surname>Laversanne</surname><given-names>M.</given-names></name><name><surname>Sung</surname><given-names>H.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Siegel</surname><given-names>R.L.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><year>2024</year><pub-id pub-id-type="doi">10.3322/caac.21834</pub-id></element-citation></ref><ref id="BIBR-3"><element-citation publication-type="journal"><article-title>Counting small particles in electron microscopy images-proposal for rules and their application in practice</article-title><source>Nanomaterials (Basel</source><volume>12</volume><issue>13</issue><person-group person-group-type="author"><name><surname>Bresch</surname><given-names>H.</given-names></name><name><surname>Hodoroaba</surname><given-names>V.-D.</given-names></name><name><surname>Alexandra</surname><given-names>Schmidt</given-names></name><name><surname>Rasmussen</surname><given-names>K.</given-names></name><name><surname>Rauscher</surname><given-names>H.</given-names></name></person-group><year>2022</year><page-range>2238</page-range></element-citation></ref><ref id="BIBR-4"><element-citation publication-type="journal"><article-title>Dual Nanostructured Lipid Carriers/Hydrogel System for Delivery of Curcumin for Topical Skin Applications</article-title><source>Biomolecules</source><volume>12</volume><issue>6</issue><person-group person-group-type="author"><name><surname>Calderon-Jacinto</surname><given-names>R.</given-names></name><name><surname>Matricardi</surname><given-names>P.</given-names></name><name><surname>Gueguen</surname><given-names>V.</given-names></name><name><surname>Pavon-Djavid</surname><given-names>G.</given-names></name><name><surname>Pauthe</surname><given-names>E.</given-names></name><name><surname>Rodriguez-Ruiz</surname><given-names>V.</given-names></name></person-group><year>2022</year></element-citation></ref><ref id="BIBR-5"><element-citation publication-type="journal"><article-title>Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery</article-title><source>Adv. Pharm. Bull</source><volume>10</volume><issue>2</issue><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>I.</given-names></name><name><surname>Yasir</surname><given-names>M.</given-names></name><name><surname>Verma</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>A.P.</given-names></name></person-group><year>2020</year><fpage>150</fpage><lpage>165</lpage><page-range>150-165</page-range></element-citation></ref><ref id="BIBR-6"><element-citation publication-type="journal"><article-title>Optimized protocol to isolate primary mouse peritoneal macrophage metabolites</article-title><source>STAR Protoc</source><volume>3</volume><issue>4</issue><person-group person-group-type="author"><name><surname>Jesus</surname><given-names>A.</given-names></name><name><surname>Pusec</surname><given-names>C.M.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Keyhani-Nejad</surname><given-names>F.</given-names></name><name><surname>Gao</surname><given-names>P.</given-names></name><name><surname>Weinberg</surname><given-names>S.E.</given-names></name><name><surname>Ardehali</surname><given-names>H.</given-names></name></person-group><year>2022</year><page-range>101668</page-range></element-citation></ref><ref id="BIBR-7"><element-citation publication-type="book"><article-title>Dr. Duke’s phytochemical and ethnobotanical databases</article-title><person-group person-group-type="author"><name><surname>Duke</surname><given-names>J.A.</given-names></name></person-group><year>2016</year><publisher-name>Ag Data Commons</publisher-name></element-citation></ref><ref id="BIBR-8"><element-citation publication-type="journal"><article-title>Curcumin-infused nanostructured lipid carriers: a promising strategy for enhancing skin regeneration and combating microbial infection</article-title><source>BMC Vet. Res</source><volume>19</volume><issue>1</issue><person-group person-group-type="author"><name><surname>Elkhateeb</surname><given-names>O.</given-names></name><name><surname>Badawy</surname><given-names>M.E.I.</given-names></name><name><surname>Tohamy</surname><given-names>H.G.</given-names></name><name><surname>Abou-Ahmed</surname><given-names>H.</given-names></name><name><surname>El-Kammar</surname><given-names>M.</given-names></name><name><surname>Elkhenany</surname><given-names>H.</given-names></name></person-group><year>2023</year><page-range>206</page-range></element-citation></ref><ref id="BIBR-9"><element-citation publication-type="book"><article-title>Histology, alveolar macrophages</article-title><source>StatPearls</source><person-group person-group-type="author"><name><surname>Fakoya</surname><given-names>A.O.</given-names></name><name><surname>Naeem</surname><given-names>A.</given-names></name><name><surname>Pierre</surname><given-names>L.</given-names></name></person-group><year>2025</year><publisher-name>StatPearls Publishing</publisher-name></element-citation></ref><ref id="BIBR-10"><element-citation publication-type="journal"><article-title>Macrophages in tumor cell migration and metastasis</article-title><source>Frontiers in Immunology</source><volume>15-2024</volume><person-group person-group-type="author"><name><surname>Friedman-DeLuca</surname><given-names>M.</given-names></name><name><surname>Karagiannis</surname><given-names>G.S.</given-names></name><name><surname>Condeelis</surname><given-names>J.S.</given-names></name><name><surname>Oktay</surname><given-names>M.H.</given-names></name><name><surname>Entenberg</surname><given-names>D.</given-names></name></person-group><year>2024</year><pub-id pub-id-type="doi">10.3389/fimmu.2024.1494462</pub-id></element-citation></ref><ref id="BIBR-11"><element-citation publication-type="journal"><article-title>Estimation of cell number by hemocytometry counting</article-title><source>Cold Spring Harb. Protoc</source><volume>2019</volume><issue>11</issue><person-group person-group-type="author"><name><surname>Green</surname><given-names>M.R.</given-names></name><name><surname>Sambrook</surname><given-names>J.</given-names></name></person-group><year>2019</year><page-range>097980</page-range></element-citation></ref><ref id="BIBR-12"><element-citation publication-type="book"><article-title>NIST - NCL Joint Assay Protocol, PCC-1</article-title><person-group person-group-type="author"><name><surname>Hackley</surname><given-names>V.</given-names></name><name><surname>Clogston</surname><given-names>J.</given-names></name></person-group><year>2020</year><publisher-name>NCIP Hub</publisher-name></element-citation></ref><ref id="BIBR-13"><element-citation publication-type="journal"><article-title>Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer</article-title><source>Int. J. Pharm</source><volume>587</volume><issue>119705</issue><person-group person-group-type="author"><name><surname>Imran</surname><given-names>M.</given-names></name><name><surname>Iqubal</surname><given-names>M.K.</given-names></name><name><surname>Khalid</surname><given-names>Imtiyaz</given-names></name><name><surname>Saleem</surname><given-names>S.</given-names></name><name><surname>Mittal</surname><given-names>S.</given-names></name><name><surname>A</surname><given-names>Rizvi M.Moshahid</given-names></name><name><surname>Ali</surname><given-names>J.</given-names></name><name><surname>Baboota</surname><given-names>S.</given-names></name></person-group><year>2020</year><page-range>119705</page-range></element-citation></ref><ref id="BIBR-14"><element-citation publication-type="journal"><article-title>Alliums as potential antioxidants and anticancer agents</article-title><source>Int. J. Mol. Sci</source><volume>25</volume><issue>15</issue><person-group person-group-type="author"><name><surname>Iwar</surname><given-names>K.</given-names></name><name><surname>Ochar</surname><given-names>K.</given-names></name><name><surname>Seo</surname><given-names>Y.A.</given-names></name><name><surname>Ha</surname><given-names>B.-K.</given-names></name><name><surname>Kim</surname><given-names>S.-H.</given-names></name></person-group><year>2024</year><page-range>8079</page-range></element-citation></ref><ref id="BIBR-15"><element-citation publication-type="journal"><article-title>On the Structure, Stability, and Cell Uptake of Nanostructured Lipid Carriers for Drug Delivery</article-title><source>Molecular Pharmaceutics</source><volume>21</volume><issue>7</issue><person-group person-group-type="author"><name><surname>Jeitler</surname><given-names>R.</given-names></name><name><surname>Glader</surname><given-names>C.</given-names></name><name><surname>König</surname><given-names>G.</given-names></name><name><surname>Kaplan</surname><given-names>J.</given-names></name><name><surname>Tetyczka</surname><given-names>C.</given-names></name><name><surname>Remmelgas</surname><given-names>J.</given-names></name><name><surname>Mußbacher</surname><given-names>M.</given-names></name><name><surname>Fröhlich</surname><given-names>E.</given-names></name><name><surname>Roblegg</surname><given-names>E.</given-names></name></person-group><year>2024</year><fpage>3674</fpage><lpage>3683</lpage><page-range>3674-3683</page-range></element-citation></ref><ref id="BIBR-16"><element-citation publication-type="webpage"><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.4c00392</pub-id></element-citation></ref><ref id="BIBR-17"><element-citation publication-type="journal"><article-title>Understanding immune-modulatory efficacy in vitro</article-title><source>Chem. Biol. Interact</source><volume>352</volume><issue>109776</issue><person-group person-group-type="author"><name><surname>Khatua</surname><given-names>S.</given-names></name><name><surname>Simal-Gandara</surname><given-names>J.</given-names></name><name><surname>Acharya</surname><given-names>K.</given-names></name></person-group><year>2022</year><page-range>109776</page-range></element-citation></ref><ref id="BIBR-18"><element-citation publication-type="journal"><article-title>PubChem 2023 update</article-title><source>Nucleic Acids Res</source><volume>51</volume><issue>D1</issue><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>T.</given-names></name><name><surname>Gindulyte</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Shoemaker</surname><given-names>B.A.</given-names></name><name><surname>Thiessen</surname><given-names>P.A.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Leonid</surname><given-names>Zaslavsky</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Bolton</surname><given-names>E.E.</given-names></name></person-group><year>2023</year><fpage>1373</fpage><lpage>1380</lpage><page-range>1373-1380</page-range></element-citation></ref><ref id="BIBR-19"><element-citation publication-type="journal"><article-title>Modern methods of pre-treatment of plant material for the extraction of bioactive compounds</article-title><source>Molecules</source><volume>27</volume><issue>3</issue><person-group person-group-type="author"><name><surname>Krakowska-Sieprawska</surname><given-names>A.</given-names></name><name><surname>Kiełbasa</surname><given-names>A.</given-names></name><name><surname>Rafińska</surname><given-names>K.</given-names></name><name><surname>Ligor</surname><given-names>M.</given-names></name><name><surname>Buszewski</surname><given-names>B.</given-names></name></person-group><year>2022</year><page-range>730</page-range></element-citation></ref><ref id="BIBR-20"><element-citation publication-type="journal"><article-title>Nanostructured lipid carriers for topical drug delivery: A comprehensive review of design, mechanisms, and therapeutic advances</article-title><source>Next Nanotechnology</source><volume>9</volume><person-group person-group-type="author"><name><surname>Kumari</surname><given-names>M.</given-names></name><name><surname>Gohil</surname><given-names>D.</given-names></name><name><surname>Sadhu</surname><given-names>P.</given-names></name></person-group><year>2026</year><page-range>100367</page-range><pub-id pub-id-type="doi">10.1016/j.nxnano.2026.100367</pub-id></element-citation></ref><ref id="BIBR-21"><element-citation publication-type="journal"><article-title>Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: Perspectives of materials and particle design</article-title><source>Advances in Colloid and Interface Science</source><volume>325</volume><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S.H.</given-names></name><name><surname>Wong</surname><given-names>T.W.</given-names></name><name><surname>Tay</surname><given-names>W.X.</given-names></name></person-group><year>2024</year><page-range>103094</page-range><pub-id pub-id-type="doi">10.1016/j.cis.2024.103094</pub-id></element-citation></ref><ref id="BIBR-22"><element-citation publication-type="journal"><article-title>STNM1 in human cancers: role, function and potential therapy sensitizer</article-title><source>Cellular Signalling</source><volume>109</volume><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Yao</surname><given-names>W.</given-names></name><name><surname>Dong</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group><year>2023</year><page-range>110775</page-range><pub-id pub-id-type="doi">10.1016/j.cellsig.2023.110775</pub-id></element-citation></ref><ref id="BIBR-23"><element-citation publication-type="journal"><article-title>Trolox, Ferulic, Sinapic, and Cinnamic Acid Derivatives of Proline and GABA with Antioxidant and/or Anti-Inflammatory Properties</article-title><source>Molecules</source><volume>29</volume><issue>16</issue><person-group person-group-type="author"><name><surname>Papagiouvannis</surname><given-names>G.</given-names></name><name><surname>Theodosis-Nobelos</surname><given-names>P.</given-names></name><name><surname>Rekka</surname><given-names>E.A.</given-names></name></person-group><year>2024</year><pub-id pub-id-type="doi">10.3390/molecules29163763</pub-id></element-citation></ref><ref id="BIBR-24"><element-citation publication-type="journal"><article-title>Quantitative analysis of latex beads phagocytosis by human macrophages using imaging flow cytometry with extended depth of field (EDF</article-title><source>Methods Mol. Biol</source><volume>2635</volume><person-group person-group-type="author"><name><surname>Pavlova</surname><given-names>E.</given-names></name><name><surname>Shaposhnikova</surname><given-names>D.</given-names></name><name><surname>Petrichuk</surname><given-names>S.</given-names></name><name><surname>Radygina</surname><given-names>T.</given-names></name><name><surname>Erokhina</surname><given-names>M.</given-names></name></person-group><year>2023</year><fpage>203</fpage><lpage>215</lpage><page-range>203-215</page-range></element-citation></ref><ref id="BIBR-25"><element-citation publication-type="journal"><article-title>Comparative assessment of macrophage responses and antileishmanial efficacy in dynamic vs. Static culture systems utilizing chitosan-based formulations</article-title><source>PLOS ONE</source><volume>20</volume><issue>3</issue><person-group person-group-type="author"><name><surname>Riezk</surname><given-names>A.</given-names></name><name><surname>O’Keeffe</surname><given-names>A.</given-names></name><name><surname>Bocxlaer</surname><given-names>K.</given-names></name><name><surname>Yardley</surname><given-names>V.</given-names></name><name><surname>Croft</surname><given-names>S.L.</given-names></name></person-group><year>2025</year><page-range>0319610-</page-range><pub-id pub-id-type="doi">10.1371/journal.pone.0319610</pub-id></element-citation></ref><ref id="BIBR-26"><element-citation publication-type="journal"><article-title>Ferulic, Sinapic, 3,4-Dimethoxycinnamic Acid and Indomethacin Derivatives with Antioxidant, Anti-Inflammatory and Hypolipidemic Functionality</article-title><source>Antioxidants</source><volume>12</volume><issue>7</issue><person-group person-group-type="author"><name><surname>Theodosis-Nobelos</surname><given-names>P.</given-names></name><name><surname>Papagiouvannis</surname><given-names>G.</given-names></name><name><surname>Rekka</surname><given-names>E.A.</given-names></name></person-group><year>2023</year><pub-id pub-id-type="doi">10.3390/antiox12071436</pub-id></element-citation></ref><ref id="BIBR-27"><element-citation publication-type="journal"><article-title>AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title><source>J. Comput. Chem</source><volume>31</volume><issue>2</issue><person-group person-group-type="author"><name><surname>Trott</surname><given-names>O.</given-names></name><name><surname>Olson</surname><given-names>A.J.</given-names></name></person-group><year>2010</year><fpage>455</fpage><lpage>461</lpage><page-range>455-461</page-range></element-citation></ref><ref id="BIBR-28"><element-citation publication-type="journal"><article-title>Phagocytosis of microparticles increases responsiveness of macrophage-like cell lines U937 and THP-1 to bacterial lipopolysaccharide and lipopeptide</article-title><source>Scientific Reports</source><volume>11</volume><issue>1</issue><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><name><surname>Kawasaki</surname><given-names>K.</given-names></name></person-group><year>2021</year><page-range>6782</page-range><pub-id pub-id-type="doi">10.1038/s41598-021-86202-5</pub-id></element-citation></ref><ref id="BIBR-29"><mixed-citation publication-type="journal">Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., Yuan, D., Stroe, O., Wood, G., Laydon, A., Žídek, A., Green, T., Tunyasuvunakool, K., Petersen, S., Jumper, J., Clancy, E., Green, R.,</mixed-citation></ref><ref id="BIBR-30"><element-citation publication-type="journal"><article-title>AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title><source>Nucleic Acids Research</source><volume>50</volume><issue>D1</issue><person-group person-group-type="author"><name><surname>Vora</surname><given-names>A.</given-names></name><name><surname>Lutfi</surname><given-names>M.</given-names></name><name><surname>Velankar</surname><given-names>S.</given-names></name><etal/></person-group><year>2022</year><fpage>439</fpage><lpage>444</lpage><page-range>439-444</page-range><pub-id pub-id-type="doi">10.1093/nar/gkab1061</pub-id></element-citation></ref><ref id="BIBR-31"><element-citation publication-type="journal"><article-title>Highlights of infectious agents in tissue</article-title><source>Pathology</source><volume>54</volume><issue>2</issue><person-group person-group-type="author"><name><surname>Velez-Hoyos</surname><given-names>A.</given-names></name><name><surname>Jimenez-tobon</surname><given-names>G.A.</given-names></name></person-group><year>2022</year><fpage>217</fpage><lpage>224</lpage><page-range>217-224</page-range><pub-id pub-id-type="doi">10.1016/j.pathol.2021.10.004</pub-id></element-citation></ref><ref id="BIBR-32"><element-citation publication-type="journal"><article-title>STMN1 promotes tumor metastasis in non-small cell lung cancer through microtubule-dependent and nonmicrotubule-dependent pathways</article-title><source>Int. J. Biol. Sci</source><volume>20</volume><issue>4</issue><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>L.</given-names></name><name><surname>Lyu</surname><given-names>X.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name></person-group><year>2024</year><fpage>1509</fpage><lpage>1527</lpage><page-range>1509-1527</page-range></element-citation></ref></ref-list></back></article>